microenvironment

Documents about microenvironment

• The Microenvironment in Barrett's Esophagus#850718ClinicalTrials.gov
• Heterogeneous tumor microenvironment - A hallmark of ameloblastoma invasive phenotype#989814ScholarlyCommons at Penn
• Heterogeneous tumor microenvironment - A hallmark of ameloblastoma invasive phenotype#989835ScholarlyCommons
• Nanoimmunomodulation for cartilage repair in osteoarthritis: reprogramming the inflammatory joint microenvironment#784658Europe PMC
• Tumor Microenvironment#321719ClinicalTrials.gov
• Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy#407738ClinicalTrials.gov
• Potential Immune Microenvironment Biomarkers in SCLC: J-TAIL-2 Observational Study#309400OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Sleep Disorders and Tumor Immune Microenvironment#674895ClinicalTrials.gov
• Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer#883029ClinicalTrials.gov
• Role of radiation therapy in modulation of the tumor stroma and microenvironment#955521Koc University Digital Collections
• Targeting cellular components of the tumor microenvironment in solid malignancies#424948IRIS
• Reprogramming the Tumor Microenvironment in Desmoplastic Tumors to Potentiate Cancer Immunotherapy#643416Harvard DASH
• Reprogramming the Tumor Microenvironment in Desmoplastic Tumors to Potentiate Cancer Immunotherapy#643468Harvard DASH
• Evaluation of immune microenvironment in non-small cell lung carcinoma after neoadjuvant immunotherapy. A case report#320316IRIS
• Profiling tumor immune microenvironment of epithelial ovarian carcinoma.#686618PubMed
• Vaginal Probiotics and Pessaries and Their Impact on the Vaginal Microenvironment#811171ClinicalTrials.gov
• Intratumoral Microbiota and Immune Microenvironment in Prostate Cancer#802072ClinicalTrials.gov
• Decoding the microbiome: artificial intelligence-targeted gut microenvironment breakthroughs in personalized cancer therapy.#244567PubMed
• NUAK2 Inhibition Enhances Macromolecular Drug Delivery in a 3D Fibrotic Model of the Pancreatic Tumor Microenvironment#653887OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Correlation Between Specific Gene Mutationand Local Immune Microenvironment and Immunotherapy Efficacy in NSCLC#994156ClinicalTrials.gov
• Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypes.#9949PubMed
• Iron Metabolism in the Colorectal Tumor Microenvironment: From Preneoplastic Lesions to Cancer Progression#314727Europe PMC
• Recent progress in small molecules targeting the acidic tumor microenvironment#651911Europe PMC
• Integrating microenvironment tailoring into molecular electrocatalysis#684934HAL (France)
• Recent advances in chemiluminescence probes for Tumor microenvironment with applications in cancer diagnosis and therapy#4536Europe PMC
• Computational Framework for Acidity-Responsive Regulation in Tumor–Immune Microenvironment Dynamics#187135Zenodo (CERN)
• Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy#268002ClinicalTrials.gov
• Colorectal cancer landscape from gut microbiota: Insights into mutations, epigenetic dysregulation, and immune microenvironment alterations#642675Europe PMC
• Multi-omics analysis identified SPRR2D as a potential biomarker for tumor prognosis and immune microenvironment infiltration: a pan-cancer perspective#5080Europe PMC
• The dual role of leukotrienes in the tumor microenvironment: balancing pro-tumorigenic and anti-tumor immunity#478505Europe PMC
• Image 5_HIST1H2BJ is associated with poor prognosis and an immune-altered tumor microenvironment in glioma.pdf#922327Figshare
• Image 3_HIST1H2BJ is associated with poor prognosis and an immune-altered tumor microenvironment in glioma.pdf#922328Figshare
• Image 4_HIST1H2BJ is associated with poor prognosis and an immune-altered tumor microenvironment in glioma.tif#922329Figshare
• Image 1_HIST1H2BJ is associated with poor prognosis and an immune-altered tumor microenvironment in glioma.jpeg#922330Figshare
• Image 2_HIST1H2BJ is associated with poor prognosis and an immune-altered tumor microenvironment in glioma.tif#922332Figshare
• Table 1_HIST1H2BJ is associated with poor prognosis and an immune-altered tumor microenvironment in glioma.xlsx#922335Figshare
• Sonoporation and Tumor Microenvironment Response in Colorectal Liver Metastases#915948ClinicalTrials.gov
• Data Sheet 3_HIST1H2BJ is associated with poor prognosis and an immune-altered tumor microenvironment in glioma.docx#922334Figshare
• The CAGE Framework (Calcium-Gated Excitability): From Single Neurotransmitters to Calcium States in the Tumor Microenvironment#970744Europe PMC
• Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study#980302ClinicalTrials.gov
• The tumor microenvironment in triple negative breast cancer and a strategy to improve responses to immunotherapy using cryoablation and immunostimulants#273474Europe PMC
• Unveiling the immune microenvironment in sinonasal intestinal type adenocarcinoma: new arguments for immunotherapy#661999HAL (France)
• The CAGE Framework (Calcium-Gated Excitability): From Single Neurotransmitters to Calcium States in the Tumor Microenvironment#784434Europe PMC
• Renal Cell Carcinoma Microenvironment Discovery Project#180401ClinicalTrials.gov
• The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem#291645HAL (France)
• The immunosuppressive tumor microenvironment in glioblastoma.#378516NCBI PubMed Central
• Preclinical advances and mechanistic insights of CAR-T therapy for acute myeloid leukemia: from target iteration to microenvironment regulation#4573Europe PMC
• Role of the Tumor Microenvironment in Aggressive Meningiomas#467567ClinicalTrials.gov
• Microenvironment of Adipose Tissue in Endocannabinoid System#888140ClinicalTrials.gov
• Research progress on the compositional characteristics of the tumor immune microenvironment and immunopredictive models in esophageal squamous cell carcinoma#4567Europe PMC